In our study, we found COL6A3 is highly expressed in colon cancer, and its expression correlate with poor survival outcomes, which further emphasized the crucial role of COL6A3 as a tumor promoter in colorectal carcinoma. Here, COL6A3 is linked to malignant colon neoplasm.